Medical Condition News

RSS

UCI researchers receive $2.27M to develop innovative methods of treating Type 1 diabetes.

Two UC Irvine research groups have received $2.27 million from the JDRF to develop innovative methods of treating and possibly curing Type 1 diabetes.

27 Jun 2013

Edge Therapeutics announces positive preliminary results from EG-1962 study for prevention of DCI

Edge Therapeutics announced today positive preliminary results from the first human use of EG-1962, the Company's novel bioabsorbable nimodipine microparticle formulation for the prevention of delayed cerebral ischemia, a life-threatening complication of subarachnoid hemorrhage, typically resulting from a ruptured brain aneurysm or traumatic brain injury.

27 Jun 2013

Researchers use mobile application to improve asthma outcomes among minority adolescents

Researchers at Rush University Medical Center in Chicago, IL and The University of Illinois at Chicago are using the Internet and motivational multimedia coupled with positive reinforcement via a smartphone application to try to improve asthma outcomes among low-income, minority adolescents with asthma.

27 Jun 2013

UH receives NIDA grant to study transdiagnostic CBT to address tobacco cessation

According to the Centers for Disease Control and Prevention, tobacco use continues to be the leading preventable cause of death in the U.S. resulting in more than 440,000 premature deaths a year. An additional 25 million smokers will most likely die of a smoking related illness.

27 Jun 2013

Sleep apnea severity higher among African-American men, WSU researcher finds

A Wayne State University researcher has found that sleep apnea severity is higher among African-American men in certain age ranges, even after controlling for body mass index.

27 Jun 2013

Innate worriers are more vulnerable to impacts of sleep loss, find UC Berkeley neuroscientists

UC Berkeley researchers have found that a lack of sleep, which is common in anxiety disorders, may play a key role in ramping up the brain regions that contribute to excessive worrying.

27 Jun 2013

University of Sheffield researchers show how human skin constantly regrows

We constantly grow new skin and slough off the old. Until now, scientists have never agreed on exactly how this works, but new research from the University of Sheffield may provide the answer.

27 Jun 2013

Scientists make important step forward to find cure for cancer

Scientists at the University of East Anglia have made a major advancement in understanding tissue development that has important implications for cancer.

27 Jun 2013

Manchester researchers launch new project to better understand causes of RA

Researchers in Manchester have this week launched an innovative new project working with patients and their families to better understand the causes of rheumatoid arthritis.

27 Jun 2013

Michael Nissenblatt to receive St. George National Award for outstanding service to combat cancer

Regional Cancer Care Associates LLC, one of the largest oncology physician networks in the nation, is pleased to announce that Michael Nissenblatt, M.D. has been selected as one of 25 nationally recognized individuals to receive the American Cancer Society's St. George National Award for outstanding service to the community in support of the Society's mission to combat cancer.

27 Jun 2013

Researchers study possible alternative medications to treat cancer-related pain

Researchers at the Brain and Spine Institute at John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, are studying a possible alternative to side effect-ridden opioid-based medications to treat cancer-related pain.

27 Jun 2013

FX006 demonstrates pain relief in Phase 2b osteoarthritis study, Flexion reports

Flexion Therapeutics, Inc., today reported that its lead compound FX006, a novel intra-articular, sustained release steroid, demonstrated pain relief that is of both greater magnitude and longer duration than the most commonly prescribed immediate release steroid, triamcinolone acetonide, in a Phase 2b dose-ranging trial in osteoarthritis.

27 Jun 2013

Ambit Biosciences presents data from Phase 2 ACE study of quizartinib for treatment of AML

Ambit Biosciences Corporation announced today data from the Phase 2 ACE study of quizartinib (AC220), a FLT3 inhibitor, were featured in multiple presentations at the 18th Congress of the European Hematology Association in Stockholm, Sweden.

27 Jun 2013

FDA grants fast track designation to Genervon Biopharmaceuticals for ALS drug GM604

In a huge victory for ALS sufferers, FDA granted Genervon Biopharmaceuticals a fast track designation for its first in class highly effective multi-target master regulator biotechnology drug GM604 for ALS. FDA said it met the necessary criteria.

27 Jun 2013

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

MorphoSys AG and Celgene Corporation today announced an agreement to jointly develop MOR202 globally and to co-promote MOR202 in Europe.

27 Jun 2013

Low-molecular-weight PAHs promote conditions for cancer growth

Tobacco smoke, diesel exhaust and oil combustion carry polycyclic aromatic hydrocarbons - PAHs that are known to cause cancer. But of these PAHs, the obviously dangerous high-molecular-weight PAHs like benzo[a]pyrene (BaP) have received the vast majority of research attention.

26 Jun 2013

Kiadis Pharma to receive innovation credit from AgentschapNL to conduct Phase II study for ATIR

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that it will receive an innovation credit of up to €3 million from AgentschapNL, a division of the Dutch Ministry of Economic Affairs, to support the Phase II clinical development of Kiadis Pharma's lead pipeline product, ATIR™

26 Jun 2013

Researchers say genetics and life experience independently protect against cognitive decline in MS

U.S. and Italian researchers have determined that brain reserve, as well as cognitive reserve, independently protects against cognitive decline in multiple sclerosis (MS). Their article, "Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it", was published in Neurology on June 11, 2013.

26 Jun 2013

Johns Hopkins students design device to reduce need for repeated breast cancer surgeries

When a breast tumor is detected, many women opt to have a lumpectomy, which is surgery designed to remove the diseased tissue while preserving the breast. But during this procedure, doctors cannot learn right away whether all of the cancerous tissue has been removed, with no microscopic signs that cancer cells were left behind.

26 Jun 2013

Survey finds at least 20% of Ontario adolescents had TBI in their lifetime

One in five adolescents surveyed in Ontario said they have suffered a traumatic brain injury that left them unconscious for five minutes or required them to be hospitalized overnight, a statistic researchers in Toronto say is much higher than previously thought.

26 Jun 2013

Medical Condition News

UCI researchers receive $2.27M to develop innovative methods of treating Type 1 diabetes.

Edge Therapeutics announces positive preliminary results from EG-1962 study for prevention of DCI

Researchers use mobile application to improve asthma outcomes among minority adolescents

UH receives NIDA grant to study transdiagnostic CBT to address tobacco cessation

Sleep apnea severity higher among African-American men, WSU researcher finds

Innate worriers are more vulnerable to impacts of sleep loss, find UC Berkeley neuroscientists

University of Sheffield researchers show how human skin constantly regrows

Scientists make important step forward to find cure for cancer

Manchester researchers launch new project to better understand causes of RA

Michael Nissenblatt to receive St. George National Award for outstanding service to combat cancer

Researchers study possible alternative medications to treat cancer-related pain

FX006 demonstrates pain relief in Phase 2b osteoarthritis study, Flexion reports

Ambit Biosciences presents data from Phase 2 ACE study of quizartinib for treatment of AML

FDA grants fast track designation to Genervon Biopharmaceuticals for ALS drug GM604

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

Low-molecular-weight PAHs promote conditions for cancer growth

Kiadis Pharma to receive innovation credit from AgentschapNL to conduct Phase II study for ATIR

Researchers say genetics and life experience independently protect against cognitive decline in MS

Johns Hopkins students design device to reduce need for repeated breast cancer surgeries

Survey finds at least 20% of Ontario adolescents had TBI in their lifetime

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News